AQST vs EQIX · rev $28.3M vs P/E 79, rev $5.07B
Aquestive Therapeutics Inc (AQST) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
AQST currently screens at market cap $493.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the AQST and EQIX stock pages for the full models.
Not investment advice.